Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol

• Published in: Scientific reports Vol. 7; no. 1; p. 43580
• Main Authors: Dickens, David, Chiduza, George N, Wright, Gareth S A, Pirmohamed, Munir, Antonyuk, Svetlana V, Hasnain, S Samar
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 08.03.2017
• Subjects: Amino Acid Motifs; Amino Acid Sequence; Amino Acids - metabolism; Binding Sites; Biological Transport - drug effects; Cancer; Cholesterol; Cholesterol - chemistry; Cholesterol - metabolism; Dihydroxyphenylalanine; Dopamine transporter; Endothelial cells; Fusion Regulatory Protein-1 - metabolism; Gene Expression; Humans; Kinetics; Large Neutral Amino Acid-Transporter 1 - chemistry; Large Neutral Amino Acid-Transporter 1 - genetics; Large Neutral Amino Acid-Transporter 1 - metabolism; Levodopa; Levodopa - metabolism; Levodopa - pharmacology; Lipid Metabolism - drug effects; Lipids; Lymphocytes T; Membrane Lipids - metabolism; Models, Molecular; Protein Binding; Protein Conformation; Protein Interaction Domains and Motifs
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep43580

LAT1 (SLC7A5) is a transporter for both the uptake of large neutral amino acids and a number of pharmaceutical drugs. It is expressed in numerous cell types including T-cells, cancer cells and brain endothelial cells. However, mechanistic knowledge of how it functions and its interactions with lipids are unknown or limited due to inability of obtaining stable purified protein in sufficient quantities. Our data show that depleting cellular cholesterol reduced the V but not the K of the LAT1 mediated uptake of a model substrate into cells (L-DOPA). A soluble cholesterol analogue was required for the stable purification of the LAT1 with its chaperon CD98 (4F2hc,SLC3A2) and that this stabilised complex retained the ability to interact with a substrate. We propose cholesterol interacts with the conserved regions in the LAT1 transporter that have been shown to bind to cholesterol/CHS in Drosophila melanogaster dopamine transporter. In conclusion, LAT1 is modulated by cholesterol impacting on its stability and transporter activity. This novel finding has implications for other SLC7 family members and additional eukaryotic transporters that contain the LeuT fold.